**Core Concept:** AJCC stands for American Joint Committee on Cancer, which is a widely used staging system for cancer. In the 8th edition, pancreatic cancer staging considers tumor size and spread to nearby structures such as the portal vein.

**Why the Correct Answer is Right:** In the AJCC 8th edition, pancreatic cancer staging is determined based on the TNM (Tumor, Node, Metastasis) system. T stands for Tumor (primary tumor), M stands for Metastasis (spread to other organs), and N stands for Node (involvement of nearby lymph nodes). For pancreatic cancer, T2 is a tumor measuring between 2 cm to 5 cm in size. Involving the portal vein (Pv) increases the stage because it indicates more advanced local invasion and impact on nearby structures.

**Why Each Wrong Option is Incorrect:**

A. AJCC 8th edition considers tumor size, but not the presence of a "capsule." Therefore, Option A is incorrect.
B. AJCC 8th edition staging does not depend on the presence of "capsule." Hence, Option B is incorrect.
C. AJCC 8th edition staging is based on tumor size and involvement of nearby structures like the portal vein, so Option C is incorrect.
D. AJCC 8th edition staging is based on tumor size and invasion of nearby structures like the portal vein. Option D is incorrect because it does not address the presence of a capsule or the lymph node status (N).

**Clinical Pearl:** In pancreatic cancer diagnosis and staging, the involvement of the portal vein is a significant factor that increases the stage and indicates more advanced disease. This may impact treatment options and prognosis for the patient. It is crucial for physicians to accurately assess these factors when staging pancreatic cancer.